Octagos Health, Inc. Company Profile

Background

Overview

Octagos Health, Inc., founded in 2020 by Dr. Shanti Bansal, a practicing Cardiac Electrophysiologist, is a Houston-based company specializing in AI-driven remote cardiac monitoring solutions. The company aims to enhance patient outcomes by simplifying cardiac care through advanced technology and comprehensive monitoring services.

Mission and Vision

Mission: To improve patient outcomes by simplifying cardiac care.

Vision: To shape a future where patient care is seamless, precise, and accessible to all.

Primary Area of Focus

Octagos focuses on providing AI-powered, vendor-agnostic cardiac remote monitoring solutions that integrate seamlessly with electronic health records (EHRs) and various cardiac devices. Their platform aims to reduce alert fatigue, streamline workflows, and enhance patient care.

Industry Significance

In 2025, Octagos was recognized by TIME as one of the World's Top HealthTech Companies, highlighting its impact and innovation in the healthcare technology sector.

Key Strategic Focus

Core Objectives

Enhance the efficiency and accuracy of cardiac monitoring.

Reduce clinician workload and alert fatigue.

Provide seamless integration with existing healthcare systems.

Specific Areas of Specialization

AI-driven analysis of cardiac device data.

Integration with a wide range of cardiac devices and EHR systems.

Automation of clinical workflows to improve operational efficiency.

Key Technologies Utilized

Atlas AI: Proprietary AI technology that delivers precise clinical reports and reduces alert burden.

EHR Integration: Bi-directional integration with various EHR systems, often completed in less than four weeks.

Primary Markets Targeted

Cardiology clinics.

Hospitals and health systems.

Healthcare providers seeking to modernize cardiac monitoring programs.

Financials and Funding

Funding History

Total Funds Raised: Over $43 million.

Recent Funding Rounds:

Series B: In July 2024, Octagos raised over $43 million, led by Morgan Stanley Expansion Capital, with participation from Mucker Capital and other strategic investors.

Notable Investors

Morgan Stanley Expansion Capital.

Mucker Capital.

Intended Utilization of Capital

Accelerate platform enhancements.

Expand the commercial team and operations.

Integrate a broader range of devices, including wearables and remote patient monitoring systems.

Pipeline Development

As a private company, specific details about Octagos' pipeline candidates and development stages are not publicly disclosed. However, the company continues to innovate by expanding its platform to include various cardiac devices and enhancing its AI capabilities to improve predictive analytics and clinical decision-making.

Technological Platform and Innovation

Proprietary Technologies

Atlas AI: An AI-driven platform that provides accurate clinical reports and reduces alert fatigue.

Significant Scientific Methods

Human-in-the-Loop AI: Combines AI with expert human oversight to ensure high accuracy in clinical interpretations.

SMART on FHIR Standards: Ensures secure and efficient integration with EHR systems.

Leadership Team

Key Executives

Dr. Shanti Bansal: Founder and CEO. A practicing Cardiac Electrophysiologist with extensive experience in cardiac care.

Eric Olsen: Chief Operating Officer. Oversees operations and strategic initiatives.

Chris Delgado: Chief Commercial Officer. Joined in October 2024 to lead business development efforts.

Competitor Profile

Market Insights and Dynamics

The remote cardiac monitoring market is experiencing significant growth, driven by advancements in AI technology and the increasing need for efficient patient monitoring solutions. Companies like Octagos are at the forefront of this transformation, offering innovative solutions that integrate seamlessly with existing healthcare infrastructures.

Competitor Analysis

iRhythm Technologies: Offers wearable ECG monitors and cloud-based data analytics.

BioTelemetry: Provides remote cardiac monitoring services and devices.

Medtronic: Offers a range of cardiac monitoring solutions, including implantable devices and remote monitoring services.

Strategic Collaborations and Partnerships

Microsoft for Startups Pegasus Program: In July 2025, Octagos was selected for this exclusive program, gaining access to Microsoft's global enterprise ecosystem and AI-optimized cloud infrastructure.

Operational Insights

Octagos differentiates itself through its AI-driven platform, seamless EHR integrations, and commitment to reducing alert fatigue, providing a comprehensive solution for remote cardiac monitoring.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expand device integration capabilities to include a broader range of cardiac devices and wearables.

Enhance AI capabilities to provide more precise predictive analytics.

Grow the commercial team to support expansion into new markets.

Future Business Directions

Octagos aims to solidify its position as a leader in remote cardiac monitoring by continuing to innovate and expand its platform, ensuring it meets the evolving needs of healthcare providers and patients.